Flu News and Research

RSS

SEEK reports Phase I safety trail for investigational flu vaccine

SEEK, a leading UK privately-owned drug-discovery group, today presented data on the successful conclusion of a Phase I safety and tolerability study for its investigational Universal Influenza Vaccine, FLU-v, at the World Influenza Congress in Amsterdam (7-9 December).

8 Dec 2010

Scientists work together to wipe out some of the most lethal diseases

Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.

8 Dec 2010

NIH scientists consider prospects for universal influenza vaccine

The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several fronts, including finding new ways to evaluate the efficacy of vaccine candidates in clinical trials, conclude scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

7 Dec 2010

Experimental flu vaccine triggers immune response, protects against flu

Vaccine production hinges on the availability of hundreds of millions of eggs - and even with the vaccine, flu still claims somewhere around 36,000 lives in the United States during a typical year.

7 Dec 2010

Patients with H1N1 flu die due to over-reactive immune response: Research

On November 19, Jason Martin returned to the Medical Intensive Care Unit at Vanderbilt University Medical Center for the first time since he nearly died there during last year's H1N1 flu pandemic. The tall and burly Warren County, TN, ambulance worker - a 30-year-old, father of three young children - broke down and hugged some of the nurses he recognized.

6 Dec 2010

Seasonal light cycles can affect development of babies' specific brain function: Study

The season in which babies are born can have a dramatic and persistent effect on how their biological clocks function.

6 Dec 2010

Wide-scale study of flu vaccine's effectiveness in European children needed

A wide-scale study of the effectiveness of flu vaccine in children is needed in Europe to fully assess the benefits, not only in keeping the kids from getting sick, but limiting the spread of flu to adults.

4 Dec 2010

NFID supports CDC's National Influenza Vaccination Week

The National Foundation for Infectious Diseases supports the Centers for Disease Control and Prevention's annual observance of National Influenza Vaccination Week to communicate the importance and availability of influenza vaccination into the winter months and beyond. It is critical that physicians and patients, especially parents of pediatric patients, remain vigilant about flu protection this and every year.

4 Dec 2010

Information technology could improve prevention, treatment of depression

Could information technology and data mining techniques be used to improve the diagnosis and treatment of depression? That's the question scientists in Australia hope to have answered in a forthcoming issue of the International Journal of Functional Informatics and Personalised Medicine.

4 Dec 2010

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

The Infectious Disease Research Institute (IDRI) today announced it has received a $790,200 grant from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services. The grant enables technology transfer between IDRI and the Cantacuzino National Institute of Research and Development for Microbiology and Immunology (Bucharest, Romania), with the goal of producing a pandemic flu vaccine.

4 Dec 2010

Gene mutation can lead to different mental illnesses when influenced by same environmental factor

Male mice born with a genetic mutation that's believed to make humans more susceptible to schizophrenia develop behaviors that mimic other major psychiatric illnesses when their mothers are exposed to an assault to the immune system while pregnant, according to new Johns Hopkins research.

4 Dec 2010

Online program enhances patient's ability to self manage chronic health conditions: Study

A study conducted by HealthMedia, Inc. and Highmark Inc., published in the November/December edition of the American Journal of Health Promotion, proves that an online program offers a return on investment and enhances a patient's ability to self manage chronic health conditions.

2 Dec 2010

Pennsylvania Patient Safety Advisory for 2010 December focusses on tackling norovirus outbreaks

In early 2010, Pennsylvania nursing homes and hospitals reported an increased number of cases of gastrointestinal illness which are consistent with recurring outbreaks of the highly contagious norovirus and norovirus-like illnesses nationwide. With a new norovirus season approaching, the Pennsylvania Patient Safety Authority issues its 2010 December Pennsylvania Patient Safety Advisory with data analysis, guidance and success stories provided by Pennsylvania nursing homes for preventing and controlling the illness.

2 Dec 2010

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.

From Quest Diagnostics 2 Dec 2010

More effective treatment for severe form of influenza

Flu season is upon us and while getting the nasty bug is bad news, the good news is it's now possible to treat the severe form of the virus more effectively, according to a Ryerson University researcher. Though Canada is not expecting a pandemic flu season this winter Health Canada reports that about 4,000 to 8,000 Canadians die each year from flu-related pneumonia.

2 Dec 2010

New book investigates past influenza pandemics

Influenza pandemics have been among the most unpredictable and devastating natural disasters, but discussions about them are usually confined to specialists. This book makes fascinating reading for anyone who wants to understand the context of pandemics but may have been deterred by the technical detail.

1 Dec 2010

PepTcell changes name to SEEK

PepTcell, a leading UK privately-owned drug-discovery group, today announced it is changing its name to SEEK.

1 Dec 2010

Canadians at increased risk for flu complications not aware of all the facts

It starts with a headache, chills or that all-over-achy feeling. It comes on quickly, yet too many Canadians ignore the rapid onset of flu symptoms. But for the millions of Canadians at increased risk for developing serious complications from the flu, including people 65 and older, pregnant women and those with chronic medical conditions like chronic obstructive pulmonary disease (COPD), asthma, heart disease and diabetes, this 'laissez faire' attitude could be putting their health in jeopardy.

30 Nov 2010

University of Adelaide researcher leads collaboration for universal flu vaccine

A University of Adelaide researcher is leading a collaboration between Australia and Indonesia on the production of a universal flu vaccine. The frequent arising of new influenza strains represents the greatest challenge to health authorities as it renders currently available vaccines ineffective, says Dr Mohammed Alsharifi, the Head of the Vaccine Research Group at the School of Molecular and Biomedical Science, University of Adelaide.

30 Nov 2010

FDA approves Axiron topical solution CIII for testosterone replacement therapy in men

Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.

29 Nov 2010

Flu News and Research

SEEK reports Phase I safety trail for investigational flu vaccine

Scientists work together to wipe out some of the most lethal diseases

NIH scientists consider prospects for universal influenza vaccine

Experimental flu vaccine triggers immune response, protects against flu

Patients with H1N1 flu die due to over-reactive immune response: Research

Seasonal light cycles can affect development of babies' specific brain function: Study

Wide-scale study of flu vaccine's effectiveness in European children needed

NFID supports CDC's National Influenza Vaccination Week

Information technology could improve prevention, treatment of depression

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

Gene mutation can lead to different mental illnesses when influenced by same environmental factor

Online program enhances patient's ability to self manage chronic health conditions: Study

Pennsylvania Patient Safety Advisory for 2010 December focusses on tackling norovirus outbreaks

FDA grants 510(k) clearance to Focus Diagnostics Simplexa Flu A/B & RSV test on 3M Integrated Cycler

More effective treatment for severe form of influenza

New book investigates past influenza pandemics

PepTcell changes name to SEEK

Canadians at increased risk for flu complications not aware of all the facts

University of Adelaide researcher leads collaboration for universal flu vaccine

FDA approves Axiron topical solution CIII for testosterone replacement therapy in men

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News